Can hepatitis C be eradicated in the United States?

Antiviral Research

Volumn 110, Issue , 2014, Pages 79-93

  Edlin, Brian R ^a,b   Winkelstein, Emily R ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Antiviral therapy; Disease eradication; Epidemiology; Hepatitis C; Prevention; Social determinants of health

Indexed keywords

ANTIVIRAL THERAPY; CLINICAL TRIAL (TOPIC); COMMUNITY CARE; DISEASE ERADICATION; DISEASE SURVEILLANCE; DRUG SAFETY; EARLY INTERVENTION; ENZYME IMMUNOASSAY; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HEALTH SERVICE; HEPATITIS C; HIGH RISK POPULATION; HIV RAPID TEST; HUMAN; HUMAN RIGHTS; INFECTION PREVENTION; LAW ENFORCEMENT; LEADERSHIP; MASS SCREENING; PATIENT ADVOCACY; PATIENT CARE; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PRISON; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL DETERMINANTS OF HEALTH; SOCIAL STIGMA; SUBSTANCE USE; TREATMENT PLANNING; UNITED STATES; DRUG EFFECTS; GOVERNMENT; HEALTH SURVEY; HEPACIVIRUS; INFECTION CONTROL; LEGISLATION AND JURISPRUDENCE; PRIMARY PREVENTION; PROCEDURES; PUBLIC HEALTH; TRANSMISSION; CROSS TRAINING; DRUG INDUSTRY; EPIDEMIC; HEALTH CARE FACILITY; HEALTH EDUCATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OPIATE SUBSTITUTION TREATMENT; PATIENT COUNSELING; PHYSICIAN; POST EXPOSURE PROPHYLAXIS; PROBATION; RAPID TEST; SHAME; SOCIAL ASPECT; STIGMA; VIRAL CLEARANCE; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANTIVIRUS AGENT; ILLICIT DRUG; OPIATE;

ANTIVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; GOVERNMENT PROGRAMS; HEPACIVIRUS; HEPATITIS C; HUMANS; POPULATION SURVEILLANCE; PRIMARY PREVENTION; PUBLIC HEALTH; UNITED STATES;

HEPATITIS C VIRUS;

EID: 84906678391     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.07.015     Document Type: Note

References (192)

1. A.S. Abdul-Quader, J. Feelemyer, S. Modi, E.S. Stein, A. Briceno, S. Semaan, T. Horvath, G.E. Kennedy, and D.C. Des Jarlais Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review AIDS Behav. 17 9 2013 2878 2892
2. S. Albert, F.W. Brason, C.K. Sanford, N. Dasgupta, J. Graham, and B. Lovette Project Lazarus: community-based overdose prevention in rural North Carolina Pain Med. 12 Suppl. 2 2011 S77 S85
3. M. Alexander The New Jim Crow: Mass Incarceration in the Age of Colorblindness 2010 New Press New York
4. S.A. Allen, A.C. Spaulding, A.M. Osei, L.E. Taylor, A.M. Cabral, and J.D. Rich Treatment of chronic hepatitis C in a state correctional facility Ann. Intern. Med. 138 3 2003 187 190 (Pubitemid 36236128)
5. American Medical Association, 2001. Principles of Medical Ethics. Accessed at < http://www.ama-assn.org/ama/pub/physician-resources/medical- ethics/code-medical-ethics/principles-medical-ethics.page > on 8 January 2014.
6. amfAR Foundation for AIDS Research Syringe Exchange Program Coverage in the United States -July 2013 2013 amfAR Foundation for AIDS Research New York Accessed at < http://www.amfar.org/harm-reduction/ > on 8 February 2014
7. T.L. Anderson, and F. Ripullo Social setting, stigma management, and recovering drug addicts Humanit. Soc. 20 3 1996 25 43
8. G.L. Armstrong, A. Wasley, E.P. Simard, G.M. McQuillan, W.L. Kuhnert, and M.J. Alter The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann. Intern. Med. 144 10 2006 705 714 (Pubitemid 46780630)
9. E.J. Aspinall, S. Corson, J.S. Doyle, J. Grebely, S.J. Hutchinson, G.J. Dore, D.J. Goldberg, and M.E. Hellard Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis Clin. Infect. Dis. 57 Suppl. 2 2013 S80 S89
10. U. Beijer, A. Wolf, and S. Fazel Prevalence of tuberculosis, hepatitis C virus, and HIV in homeless people: a systematic review and meta-analysis Lancet Infect. Dis. 12 11 2012 859 870
11. L. Beletsky, C.S. Davis, E. Anderson, and S. Burris The law (and politics) of safe injection facilities in the United States Am. J. Public Health 98 2 2008 231 237 (Pubitemid 351317557)
12. L. Beletsky, L.E. Grau, E. White, S. Bowman, and R. Heimer The roles of law, client race and program visibility in shaping police interference with the operation of US syringe exchange programs Addiction 106 2 2011 357 365
13. L. Beletsky, A. Agrawal, B. Moreau, P. Kumar, N. Weiss-Laxer, and R. Heimer Police training to align law enforcement and HIV prevention: preliminary evidence from the field Am. J. Public Health 101 11 2011 2012 2015
14. L. Beletsky, D. Heller, S.M. Jenness, A. Neaigus, C. Gelpi-Acosta, and H. Hagan Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective Int. J. Drug Policy 25 1 2014 105 111
15. C. Beyrer, K. Malinowska-Sempruch, A. Kamarulzaman, and S.A. Strathdee 12 myths about HIV/AIDS and people who use drugs Lancet 376 9737 2010 208 211
16. G.S. Birkhead, S.J. Klein, A.R. Candelas, D.A. O'Connell, J.R. Rothman, I.S. Feldman, D.S. Tsui, R.A. Cotroneo, and C.A. Flanigan Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach Int. J. Drug Policy 18 5 2007 417 425 (Pubitemid 47376915)
17. E. Blas, L. Gilson, M.P. Kelly, R. Labonte, J. Lapitan, C. Muntaner, P. Ostlin, J. Popay, R. Sadana, G. Sen, T. Schrecker, and Z. Vaghri Addressing social determinants of health inequities: what can the state and civil society do? Lancet 372 9650 2008 1684 1689
18. S. Bowman, J. Eiserman, L. Beletsky, S. Stancliff, and R.D. Bruce Reducing the health consequences of opioid addiction in primary care Am. J. Med. 126 7 2013 565 571
19. D. Braman Doing Time on the Outside: Incarceration and Family Life in Urban America 2004 University of Michigan Press Ann Arbor
20. F.W. Brason 2nd, C. Roe, and N. Dasgupta Project Lazarus: an innovative community response to prescription drug overdose N. C. Med. J. 74 3 2013 259 261
21. I.F. Brew, C. Butt, and N. Wright Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care? Br. J. Gen. Pract. 63 617 2013 842 851
22. P. Bruggmann, and A.H. Litwin Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all Clin. Infect. Dis. 57 Suppl. 2 2013 S56 S61
23. S. Burris, J.S. Vernick, A. Ditzler, and S. Strathdee The legality of selling or giving syringes to injection drug users J. Am. Pharm. Assoc. (Wash.) 42 6 Suppl. 2 2002 S13 S38
24. R. Butkus, R. Doherty, and H. Daniel Reducing firearm-related injuries and deaths in the United States: executive summary of a policy position paper from the American College of Physicians Ann. Intern. Med. 160 12 2014 858 860
25. Centers for Disease Control and Prevention Establishing a Holistic Framework to Reduce Inequities in HIV, viral hepatitis, STDs, and Tuberculosis in the United States: An NCHHSTP White Paper on Social Determinants of Health 2010 U.S. Department of Health and Human Services, Centers for Disease Control and Prevention Atlanta Accessed at < http://www.cdc.gov/socialdeterminants/ > on 10 January 2014
26. Centers for Disease Control and Prevention Viral Hepatitis Surveillance, United States, 2011 2013 Centers for Disease Control and Prevention Atlanta, GA Accessed at < http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/index. htm > on 7 February 2014
27. K. Chan, M.N. Lai, E.J. Groessl, A.D. Hanchate, J.B. Wong, J.A. Clark, S.M. Asch, A.L. Gifford, and S.B. Ho Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration Clin. Gastroenterol. Hepatol. 11 11 2013 1503 1510
28. T.R. Clear Imprisoning Communities: How Mass Incarceration Makes Disadvantaged Neighborhoods Worse 2007 Oxford University Press New York
29. S.L. Cochi, and W.R. Dowdle The eradication of infectious diseases: understanding the lessons and advancing experience S.L. Cochi, W.R. Dowdle, Disease Eradication in the 21st Century: Implications for Global Health 2011 MIT Press Cambridge, Mass 1 10
30. N. Cocoros, E. Nettle, D. Church, L. Bourassa, V. Sherwin, K. Cranston, R. Carr, H.D. Fukuda, and A. Demaria Jr. Screening for hepatitis C as a prevention enhancement (SHAPE) for HIV: an integration pilot initiative in a Massachusetts county correctional facility Public Health Rep. 129 Suppl. 1 2014 5 11
31. P. Coffin, and C. Banta-Green The dueling obligations of opioid stewardship Ann. Intern. Med. 160 3 2014 207
32. P.O. Coffin, J.D. Scott, M.R. Golden, and S.D. Sullivan Cost-effectiveness and population outcomes of general population screening for hepatitis C Clin. Infect. Dis. 54 9 2012 1259 1271
33. C.S. Cooper Drug courts - just the beginning: getting other areas of public policy in sync Subst. Use Misuse 42 2-3 2007 243 256 (Pubitemid 46902634)
34. Costa, A.M., 2008. Making drug control "fit for purpose": Building on the UNGASS decade. Report by the Executive Director of the United Nations Office on Drugs and Crime. E/CN.7/2008/CRP.17. United Nations Office on Drugs and Crime, Vienna. Accessed at < http://www.unodc.org/documents/ commissions/CND-Session51/CND-UNGASS-CRPs/ECN72008CRP17.pdf > on 9 January 2014.
35. Count the Costs, 2013. The War on Drugs: Wasting Billions, Undermining Economies. Accessed at < http://www.countthecosts.org/seven-costs/wasting- billions-drug-law-enforcement > on 6 January 2014.
36. S. Crawford, and N. Bath Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection Clin. Infect. Dis. 57 Suppl. 2 2013 S75 S79
37. N.D. Crawford, S. Amesty, A.V. Rivera, K. Harripersaud, A. Turner, and C.M. Fuller Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City Am. J. Public Health 103 9 2013 1579 1582
38. L. Degenhardt, B. Mathers, P. Vickerman, T. Rhodes, C. Latkin, and M. Hickman Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed Lancet 376 9737 2010 285 301
39. M.M. Denniston, R.B. Jiles, J. Drobeniuc, R.M. Klevens, J.W. Ward, G.M. McQuillan, and S.D. Holmberg Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 Ann. Intern. Med. 160 5 2014 293 300
40. J. Doerrbecker, P. Behrendt, P. Mateu-Gelabert, S. Ciesek, N. Riebesehl, C. Wilhelm, J. Steinmann, T. Pietschmann, and E. Steinmann Transmission of Hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment J. Infect. Dis. 207 2013 281 287
41. K.M. Doran, E.J. Misa, and N.R. Shah Housing as health care-New York's boundary-crossing experiment N. Engl. J. Med. 369 25 2013 2374 2377
42. W.R. Dowdle Perspectives for the elimination/eradication of diseases with vaccines C.A. de Quadros, Vaccines: Preventing Disease & Protecting Health 2004 Pan American Health Organization Washington, D.C. 354 360
43. W.R. Dowdle, and S.L. Cochi The principles and feasibility of disease eradication Vaccine 29 Suppl. 4 2011 D70 D73
44. M. Downing, T.H. Riess, K. Vernon, N. Mulia, M. Hollinquest, C. McKnight, D.C. Jarlais, and B.R. Edlin What's community got to do with it? Implementation models of syringe exchange programs AIDS Educ. Prev. 17 1 2005 68 78 (Pubitemid 40289427)
45. E.M. Drucker A Plague of Prisons: The Epidemiology of Mass Incarceration in America 2011 New Press New York
46. Drug Policy Alliance Drug Courts are Not the Answer: Toward a Health-Centered Approach to Drug Use 2011 Drug Policy Alliance New York, NY Accessed at < http://www.drugpolicy.org/drugcourts > on 3 March 2014
47. T. Duster The Legislation of Morality: Law, Drugs, and Moral Judgment 1970 Free Press New York
48. Editorial A new direction for hepatitis C Lancet 383 9925 2014 1270
49. Editorial Board. Budget Grief for the Poor and Jobless. New York Times 2013 November 2:A22. Accessed at < http://www.nytimes.com/2013/11/02/opinion/ budget-grief-for-the-poor-and-jobless.html > on 8 January 2014.
50. Editorial Board. More Hunger for the Poorest Americans. New York Times 2013 December 25:A26. Accessed at < http://www.nytimes.com/2013/12/25/ opinion/more-hunger-for-the-poorest-americans.html > on 8 January 2014.
51. Editorial Board. End mass incarceration now. New York Times 2014 May 24:SR10.
52. B.R. Edlin Five million Americans infected with the hepatitis C virus: a corrected estimate Hepatology 42 4 Suppl. 1 2005 213A
53. B.R. Edlin Perspective: test and treat this silent killer Nature 474 7350 2011 S18 S19
54. B.R. Edlin Hepatitis C screening: getting it right Hepatology 57 4 2013 1644 1650
55. B.R. Edlin, and M.R. Carden Injection drug users: the overlooked core of the hepatitis C epidemic Clin. Infect. Dis. 42 5 2006 673 676 (Pubitemid 43271381)
56. B.R. Edlin, M.R. Carden, and S.J. Ferrando Managing hepatitis C in users of illicit drugs Curr. Hepat. Rep. 6 2 2007 60 67 (Pubitemid 46867371)
57. P. Farmer To Repair the World: Paul Farmer Speaks to the Next Generation 2013 University of California Press Berkeley
58. P.E. Farmer Shattuck Lecture. Chronic infectious disease and the future of health care delivery N. Engl. J. Med. 369 25 2013 2424 2436
59. M. Ferri, M. Davoli, and C.A. Perucci Heroin maintenance for chronic heroin-dependent individuals Cochrane Database Syst. Rev. 12 2011 CD003410
60. J.L. Fitzgerald Policing as public health menace in the policy struggles over public injecting Int. J. Drug Policy 16 4 2005 203 206 (Pubitemid 41558176)
61. S.M. Flanagan, and B. Hancock 'Reaching the hard to reach'-lessons learned from the VCS (voluntary and community sector). A qualitative study BMC Health Serv. Res. 10 2010 92
62. S.R. Friedman, E.R. Pouget, S. Chatterjee, C.M. Cleland, B. Tempalski, J.E. Brady, and H.L. Cooper Drug arrests and injection drug deterrence Am. J. Public Health 101 2 2011 344 349
63. C.M. Fuller, S. Galea, W. Caceres, S. Blaney, S. Sisco, and D. Vlahov Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City Am. J. Public Health 97 1 2007 117 124 (Pubitemid 46067693)
64. R.S. Garfein, D. Vlahov, N. Galai, M.C. Doherty, and K.E. Nelson Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses Am. J. Public Health 86 5 1996 655 661 (Pubitemid 26145477)
65. R.S. Garfein, M.C. Doherty, E.R. Monterroso, D.L. Thomas, K.E. Nelson, and D. Vlahov Prevalence and incidence of hepatitis C virus infection among young adult injection drug users J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 Suppl. 1 1998 S11 S19
66. L. Gelberg, M.J. Robertson, L. Arangua, B.D. Leake, G. Sumner, A. Moe, R.M. Andersen, H. Morgenstern, and A. Nyamathi Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles Public Health Rep. 127 4 2012 407 421
67. D.R. Gerstein, and H.J. Harwood Treating Drug Problems 1990 National Academy Press Washington, D.C.
68. Global Commission on Drug Policy, 2011. War on Drugs: Report of the Global Commission on Drug Policy: Global Commission on Drug Policy. Accessed at < http://www.globalcommissionondrugs.org/reports/ > on 9 January 2014.
69. Global Commission on Drug Policy, 2012. The War on Drugs and HIV/AIDS: How the Criminalization of drug Use Fuels the Global Pandemic: Global Commission on Drug Policy. Accessed at < http://www.globalcommissionondrugs.org/ hivaids-pandemic/ > on 9 January 2014.
70. Global Commission on Drug Policy, 2013. The Negative Impact of the War on Drugs on Public Health: The Hidden Hepatitis C Epidemic: Global Commission on Drug Policy. Accessed at < http://www.globalcommissionondrugs.org/hepatitis/ > on 9 January 2014.
71. E. Goffman Stigma; notes on the management of spoiled identity 1963 Prentice-Hall Englewood Cliffs, N.J.
72. A. Goffman On the Run: Fugitive Life in an American City 2014 University of Chicago Press Chicago
73. L.O. Gostin, Z. Lazzarini, T.S. Jones, and K. Flaherty Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles JAMA 277 1 1997 53 62 (Pubitemid 27009042)
74. L. Gowing, M.F. Farrell, R. Bornemann, L.E. Sullivan, and R. Ali Oral substitution treatment of injecting opioid users for prevention of HIV infection Cochrane Database Syst. Rev. 8 2011 CD004145
75. N.D. Grace, and L.B. Dennis Advocacy: what is a nice scientist like you doing in Washington, DC? Hepatology 45 6 2007 1337 1339 (Pubitemid 46918315)
76. J. Grebely, and G.J. Dore Can hepatitis C virus infection be eradicated in people who inject drugs? Antiviral Res. 104 2014 62 72
77. Greenwald, G., 2009. Drug Decriminalization in Portugal: Lessons for Creating Fair and Successful Drug Policies. Cato Institute, Washington, D.C., Accessed at < http://www.cato.org/publications/white-paper/drug- decriminalization-portugal-lessons-creating-fair-successful-drug-policies > on 9 January 2014.
78. Grover, A., 2010. Report of the Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health. A/65/255: Sixty-fifth session of the United Nations General Assembly. Accessed at < http://daccess-dds-ny.un.org/doc/UNDOC/GEN/N10/477/ 91/PDF/N1047791.pdf > on 28 January 2014.
79. R.L. Gruen, E.G. Campbell, and D. Blumenthal Public roles of US physicians: community participation, political involvement, and collective advocacy JAMA 296 20 2006 2467 2475 (Pubitemid 44791203)
80. S. Gruskin, E.J. Mills, and D. Tarantola History, principles, and practice of health and human rights Lancet 370 9585 2007 449 455 (Pubitemid 47176659)
81. H. Hagan, J.P. McGough, H. Thiede, N.S. Weiss, S. Hopkins, and E.R. Alexander Syringe exchange and risk of infection with hepatitis B and C viruses Am. J. Epidemiol. 149 3 1999 203 213 (Pubitemid 29053159)
82. H. Hagan, H. Thiede, N.S. Weiss, S.G. Hopkins, J.S. Duchin, and E.R. Alexander Sharing of drug preparation equipment as a risk factor for hepatitis C Am. J. Public Health 91 1 2001 42 46 (Pubitemid 32049265)
83. H. Hagan, E.R. Pouget, and D.C. Des Jarlais A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs J. Infect. Dis. 204 1 2011 74 83
84. J.A. Hahn, K. Page-Shafer, P.J. Lum, P. Bourgois, E. Stein, J.L. Evans, M.P. Busch, L.H. Tobler, B. Phelps, and A.R. Moss Hepatitis C virus seroconversion among young injection drug users: relationships and risks J. Infect. Dis. 186 11 2002 1558 1564 (Pubitemid 35379631)
85. T.M. Hammett, M.P. Harmon, and W. Rhodes The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997 Am. J. Public Health 92 11 2002 1789 1794 (Pubitemid 35231141)
86. L. Hanen, C. Taylor, and C. Schwartz Raising the Profile, Raising Your Voice: A Primer on Viral Hepatitis Policymaking and Programs at the Federal Level 2011 National Alliance of State & Territorial AIDS Directors Washington, DC Accessed at < http://www.nastad.org/Files/011213-NASTADPrimer- web.pdf > on 5 February 2014
87. M. Harris, E. Jolly, A. Martin, H. Wells, and T. Rhodes Barriers and Facilitators to Hepatitis C Treatment for People Who Inject Drugs: A Qualitative Study 2012 World Health Organization Copenhagen Accessed at < http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/ publications/2012/barriers-and-facilitators-to-hepatitis-c-treatment-for-people- who-inject-drugs.-a-qualitative-study > on 1 July 2014
88. Hedrich, D., Kerr, T., Dubois-Arber, F., 2010. Chapter 11: drug consumption facilities in Europe and beyond. In: Rhodes, T., Dagmar, H. (Eds.), Harm Reduction: Evidence, Impacts, and Challenges. EMCDDA Monograph No. 10. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg, pp. 305-331. Accessed at < http://www.emcdda.europa.eu/publications/monographs/ harm-reduction > on 28 January 2014.
89. M. Hellard, J.S. Doyle, R. Sacks-Davis, A.J. Thompson, and E. McBryde Eradication of hepatitis C infection: the importance of targeting people who inject drugs Hepatology 59 2 2014 366 369
90. A. Hill, S. Khoo, J. Fortunak, B. Simmons, and N. Ford Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries Clin. Infect. Dis. 58 7 2014 928 936
91. D.R. Hopkins Disease eradication N. Engl. J. Med. 368 1 2013 54 63
92. Hunt, N., Albert, E., Sánchez, V.M., 2010. Chapter 12: user involvement and user organising in harm reduction. In: Rhodes, T., Dagmar, H. (Eds.), Harm Reduction: Evidence, Impacts and Challenges. EMCDDA Monograph 10. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg, pp. 333-354. Accessed at < http://www.emcdda.europa.eu/publications/monographs/ harm-reduction > on 28 January 2014.
93. Hutchinson, S., 2013. Translating research into public health policy: the Scottish National Hepatitis C Action Plan. Third International Symposium on Hepatitis Care in Substance Users, Munich, Germany, 5-6 September 2013, Suchtmed 15(4):217. Accessed at < http://www.inhsu.com/symposium2013/thursday-5- september-presentations/ > on 3 February 2014.
94. F. Iacomi, G. Iannicelli, A. Franceschini, P. Migliorisi, S. Rosati, P. Piselli, P. Scognamiglio, G. De Carli, S. Marcellini, and F. Palmieri HCV infected prisoners: should they be still considered a difficult to treat population? BMC Infect. Dis. 13 2013 374
95. Institute of Medicine Improving the Quality of Health Care for Mental and Substance-Use Conditions 2006 National Academies Press Washington, DC
96. Institute of Medicine Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C 2010 National Academies Press Washington, DC
97. Institute of Medicine Partnering with Patients to Drive Shared Decisions, Better Value, and Care Improvement 2013 National Academies Press Washington, DC
98. J.M. Insulza The Drug Problem in the Americas 2013 Organization of American States Washington, DC Accessed at < http://www.oas.org/documents/ eng/press/Introduction-and-Analytical-Report.pdf > on 9 January 2014
99. International Network of People Who Use Drugs, 2008. Nothing about us without us. A Manifesto by People Who Use Illegal Drugs. International HIV/AIDS Alliance, Canadian HIV/AIDS Legal Network, Open Society Institute, International Network of People Who Use Drugs, International ed. Accessed at < http://www.aidsalliance.org/publicationsdetails.aspx?id=310 > on 20 March 2014.
100. Jürgens, R., 2008. "Nothing about us without us" - Greater, Meaningful Involvement of People Who Use Illegal Drugs: A Public Health, Ethical, and Human Rights Imperative. International HIV/AIDS Alliance, Canadian HIV/AIDS Legal Network, Open Society Institute, International ed., Toronto. Accessed at < http://www.aidsalliance.org/publicationsdetails.aspx? id=310 > on 20 March 2014.
101. R. Jurgens, J. Csete, J.J. Amon, S. Baral, and C. Beyrer People who use drugs, HIV, and human rights Lancet 376 9739 2010 475 485
102. T. Kerr, W. Small, and E. Wood The public health and social impacts of drug market enforcement: a review of the evidence Int. J. Drug Policy 16 4 2005 210 220 (Pubitemid 41558178)
103. S.J. Klein, L.N. Wright, G.S. Birkhead, B.A. Mojica, L.C. Klopf, L.A. Klein, E.L. Tanner, I.S. Feldman, and E.J. Fraley Promoting HCV treatment completion for prison inmates: New York State's hepatitis C continuity program Public Health Rep. 122 Suppl. 2 2007 83 88 (Pubitemid 47443838)
104. Kohli, A., Sims, Z., Nelson, A., Osinusi, A., Teferi, G., Pang, P., Symonds, W.T., McHutchison, J., Masur, H., Kottilil, S., 2014. Combination oral, hepatitis C antiviral therapy for 6 or 12 weeks: final results from the NIAID SYNERGY trial [abstract 27LB]. In: Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 3-6 March 2014: Program and Abstracts. International Antiviral Society-USA, San Francisco, pp. 102-103.
105. A.H. Kral, J. Lorvick, L. Gee, P. Bacchetti, B. Rawal, M. Busch, and B.R. Edlin Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987-1998 Am. J. Epidemiol. 157 10 2003 915 922 (Pubitemid 36555051)
106. J.R. Kramer, F. Kanwal, P. Richardson, M. Mei, and H.B. El-Serag Gaps in the achievement of effectiveness of HCV treatment in national VA practice J. Hepatol. 56 2 2012 320 325
107. J.A. Kwon, J. Iversen, L. Maher, M.G. Law, and D.P. Wilson The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis J. Acquir. Immune Defic. Syndr. 51 4 2009 462 469
108. C.M. Lange, I.M. Jacobson, C.M. Rice, and S. Zeuzem Emerging therapies for the treatment of hepatitis C EMBO Mol. Med. 6 1 2014 4 15
109. S. Larney, H. Kopinski, C.G. Beckwith, N.D. Zaller, D.D. Jarlais, H. Hagan, J.D. Rich, B.J. van den Bergh, and L. Degenhardt Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis Hepatology 58 4 2013 1215 1224
110. A. Leicht, P. Machado, G. Mackintosh, H. Roberts, E. Schatz, A. Simon, L.G. Suriol, S. Thate, and V. Vinckler Hepatitis C Among People Who Use Drugs: Key Messages from Practitioners 2011 Correlation Network Amsterdam Accessed at < http://www.correlation-net.org/hepatitis/images/pdfs/hepatitisc-key- messages-all.pdf > on 8 January 2014
111. B.G. Link, and J.C. Phelan Conceptualizing stigma Annu. Rev. Sociol. 27 2001 363 385
112. A.H. Litwin, I. Soloway, and M.N. Gourevitch Integrating services for injection drug users infected with hepatitis C virus with methadone maintenance treatment: challenges and opportunities Clin. Infect. Dis. 40 Suppl. 5 2005 S339 S345
113. J. Lorvick, A.H. Kral, K. Seal, L. Gee, and B.R. Edlin Prevalence and duration of hepatitis C among injection drug users in San Francisco Calif. Am J Public Health 91 1 2001 46 47 (Pubitemid 32049266)
114. B.D. Marshall, M.J. Milloy, E. Wood, J.S. Montaner, and T. Kerr Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study Lancet 377 9775 2011 1429 1437
115. P. Mateu-Gelabert, M.V. Gwadz, H. Guarino, M. Sandoval, C.M. Cleland, A. Jordan, H. Hagan, H. Lune, and S.R. Friedman The Staying Safe Intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV Infection AIDS Educ. Prev. 26 2 2014 144 157
116. B.M. Mathers, L. Degenhardt, B. Phillips, L. Wiessing, M. Hickman, S.A. Strathdee, A. Wodak, S. Panda, M. Tyndall, A. Toufik, and R.P. Mattick Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review Lancet 372 9651 2008 1733 1745
117. Mauer M., 2003. Comparative International Rates of Incarceration: An Examination of Causes and Trends. Presentation to the U.S. Commission on Civil Rights. Sentencing Project, Washington DC. Accessed at < http://www. sentencingproject.org/doc/publications/inc-comparative-intl.pdf > on 28 January 2014.
118. D. McLaughlin, and A. Long An extended literature review of health professionals' perceptions of illicit drugs and their clients who use them J. Psychiatr. Ment. Health Nurs. 3 5 1996 283 288 (Pubitemid 126733909)
119. A.T. McLellan, D.C. Lewis, C.P. O'Brien, and H.D. Kleber Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation JAMA 284 13 2000 1689 1695
120. B.C. McNamara, P.T. Losikoff, L. Huguenin, G.E. Macalino, J.D. Rich, and S.H. Gregory Increasing hepatitis C prevalence and associated risk behaviors among incarcerated young adults J. Urban Health 91 2 2013 376 382
121. Medical Professionalism Project Medical professionalism in the new millennium: a physician charter Ann. Intern. Med. 136 3 2002 243 246
122. S.H. Mehta, J. Astemborski, G.D. Kirk, S.A. Strathdee, K.E. Nelson, D. Vlahov, and D.L. Thomas Changes in blood-borne infection risk among injection drug users J. Infect. Dis. 203 5 2011 587 594
123. J.O. Merrill, L.A. Rhodes, R.A. Deyo, G.A. Marlatt, and K.A. Bradley Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet J. Gen. Intern. Med. 17 5 2002 327 333 (Pubitemid 34626100)
124. M. Moreira, B. Hughes, C.C. Storti, and F. Zobel Drug Policy Profiles: Portugal 2011 European Monitoring Centre for Drugs and Drug Addiction Luxembourg Accessed at < http://www.emcdda.europa.eu/publications/drug-policy-profiles/ portugal > on 9 January 2014
125. V.A. Moyer Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement Ann. Intern. Med. 159 5 2013 349 357
126. D.F. Musto The American Disease; Origins of Narcotic Control 1973 Yale University Press New Haven
127. National Research Council Understanding the Demand for Illegal Drugs 2010 National Academies Press Washington, D.C.
128. Nazario S. The Children of the Drug Wars. New York Times 2014 July 13:SR1, SR6, SR 7.
129. P.K. Nelson, B.M. Mathers, B. Cowie, H. Hagan, D. Des Jarlais, D. Horyniak, and L. Degenhardt Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews Lancet 378 9791 2011 571 583
130. C.S. North, B.A. Hong, S.A. Adewuyi, D.E. Pollio, M.K. Jain, R. Devereaux, N.A. Quartey, S. Ashitey, W.M. Lee, and M. Lisker-Melman Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations Gen. Hosp. Psychiatry 35 2 2013 122 128
131. Office of HIV/AIDS and Infectious Disease Policy Hepatitis C Virus Infection in Young Persons Who Inject Drugs: Technical Consultation Report 2013 U.S. Department of Health and Human Services Washington, D.C. Accessed at < http://aids.gov/pdf/hcv-and-young-pwid-consultation-report.pdf > on 26 January 2014
132. Office of National Drug Control Policy The Price and Purity of Illicit Drugs 2004 Executive Office of the President Washington, DC Accessed at < http://www.whitehouse.gov/ondcp/price-and-purity > on 28 January 2014
133. Y. Olsen, and J.M. Sharfstein Confronting the stigma of opioid use disorder and its treatment JAMA 311 14 2014 1393 1394
134. A. O'Mara-Eves, G. Brunton, D. McDaid, S. Oliver, J. Kavanagh, F. Jamal, T. Matosevic, A. Harden, and J. Thomas Community engagement to reduce inequalities in health: a systematic review, meta-analysis and economic analysis Public Health Res. 1 4 2013 i 525
135. E. Oviedo-Joekes, S. Brissette, D.C. Marsh, P. Lauzon, D. Guh, A. Anis, and M.T. Schechter Diacetylmorphine versus methadone for the treatment of opioid addiction N. Engl. J. Med. 361 8 2009 777 786
136. E. Paintsil, M. Binka, A. Patel, B.D. Lindenbach, and R. Heimer Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission J. Infect. Dis. 209 8 2014 1205 1211
137. J.M. Pawlotsky New hepatitis C therapies: the toolbox, strategies, and challenges Gastroenterology 146 5 2014 1176 1192
138. J.F. Perz, N.D. Thompson, M.K. Schaefer, and P.R. Patel US outbreak investigations highlight the need for safe injection practices and basic infection control Clin. Liver Dis. 14 1 2010 137 151
139. J. Petersilia When Prisoners Come Home: Parole and Prisoner Reentry 2003 Oxford University Press New York
140. H. Potts Participation and the Right to the Highest Attainable Standard of Health 2008 University of Essex Colchester Accessed at < http://www.essex.ac.uk/hrc/research/projects/rth/docs/Participation.pdf > on 26 January 2014
141. Centers for Disease Control and Prevention Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services MMWR Recomm. Rep. 61 RR-5 2012 1 43
142. T. Pugh, J. Netherland, R. Finkelstein, K. Frederique, S.M. Meeks, and G. Sayegh Blueprint for a Public Health and Safety Approach to Drug Policy 2013 New York Academy of Medicine New York Accessed at < http://www.nyam.org/drug- policy-blue-print.html > on 9 January 2014
143. C. Reinarman, and H.G. Levine Crack in America: Demon Drugs and Social Justice 1997 University of California Press Berkeley
144. J.D. Rich, M. McKenzie, G.E. Macalino, L.E. Taylor, S. Sanford-Colby, F. Wolf, S. McNamara, M. Mehrotra, and M.D. Stein A syringe prescription program to prevent infectious disease and improve health of injection drug users J. Urban Health 81 1 2004 122 134 (Pubitemid 38623007)
145. J.D. Rich, R. Chandler, B.A. Williams, D. Dumont, E.A. Wang, F.S. Taxman,
146. J.D. Rich, S.A. Allen, and B.A. Williams Responding to hepatitis C through the criminal justice system N. Engl. J. Med. 370 20 2014 1871 1874
147. R. Room Stigma, social inequality and alcohol and drug use Drug Alcohol Rev. 24 2 2005 143 155 (Pubitemid 41273067)
148. R. Sadana, and E. Blas What can public health programs do to improve health equity? Public Health Rep. 128 Suppl. 3 2013 12 20
149. D. Satterberg Law Enforcement Assisted Diversion Program 2011 King County Prosecuting Attorney's Office Seattle Accessed at < http://leadkingcounty. org/ > on 10 March 2014
150. D. Satterberg, J. Pugel, and L. Daugaard Seattle LEAD's on Law Enforcement Diversion Community Policing Dispatch 6 4 2013 Accessed at < http://cops.usdoj.gov/html/dispatch/04-2013/seattle-leads.asp > on 10 January 2014
151. E. Schatz, and M. Nougier Drug Consumption Rooms: Evidence and Practice 2012 International Drug Policy Consortium London Accessed at http://papers.ssrn.com/sol3/papers.cfm?abstract-id=2184810 on 27 January 2014
152. B. Silverman, C.S. Davis, J. Graff, U. Bhatti, M. Santos, and L. Beletsky Harmonizing disease prevention and police practice in the implementation of HIV prevention programs: up-stream strategies from Wilmington, Delaware Harm Reduct. J. 9 1 2012 17
153. L. Simmonds, and R. Coomber Injecting drug users: a stigmatised and stigmatising population Int. J. Drug Policy 20 2 2009 121 130
154. B.D. Smith, R.L. Morgan, G.A. Beckett, Y. Falck-Ytter, D. Holtzman, C.G. Teo, A. Jewett, B. Baack, D.B. Rein, N. Patel, M. Alter, A. Yartel, and J.W. Ward Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965 MMWR Recomm. Rep. 61 RR-4 2012 1 32
155. A.C. Spaulding, C.M. Weinbaum, D.T. Lau, R. Sterling, L.B. Seeff, H.S. Margolis, and J.H. Hoofnagle A framework for management of hepatitis C in prisons Ann. Intern. Med. 144 10 2006 762 769 (Pubitemid 46780636)
156. E. Springer Effective AIDS prevention with active drug users: the harm reduction model J. Chem. Depend. Treat. 4 2 1992 141 157 Accessed at < http://www.tandfonline.com/doi/abs/10.1300/J034v04n02-13?journalCode=wzcd20 > on 10 January 2014
157. M. Stepanova, F. Kanwal, H.B. El-Serag, and Z.M. Younossi Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States Hepatology 53 3 2011 737 745
158. J.E. Stiglitz The Price of Inequality: How Today's Divided Society Endangers our Future 2012 W.W. Norton New York
159. J. Strang, T. Groshkova, N. Metrebian, and European Monitoring Centre for Drugs and Drug Addiction New Heroin-Assisted Treatment: Recent Evidence and Current Practices of Supervised Injectable Heroin Treatment in Europe and Beyond 2012 Publications Office of the European Union Luxembourg Accessed at < http://www.emcdda.europa.eu/publications/insights/heroin-assisted-treatment > on 4 August 2014
160. C. Strike, S. Hopkins, T. Watson, H. Gohil, P. Leece, S. Young, J. Buxton, L. Challacombe, G. Demel, D. Heywood, H. Lampkin, L. Leonard, V.J. Lebounga, L. Lockie, P. Millson, C. Morissette, D. Nielsen, D. Petersen, D. Tzemis, and N. Zurba Best Practice Recommendations for Canadian Harm Reduction Programs that Provide Service to People Who Use Drugs and Are at Risk for HIV, HCV and Other Harms: Part 1 2013 Working Group on Best Practice for Harm Reduction Programs in Canada Toronto, ON Accessed at < http://www.fpyn.ca/ news/best-practice-recommendations-canadian-harm-reduction-programs-provide- service-people-who-use > on 20 January 2014
161. R. Subramanian, and A. Shames Sentencing and Prison Practices in Germany and the Netherlands: Implications for the United States 2013 Vera Institute of Justice New York Accessed at < http://www.vera.org/pubs/sentencing-prison- germany-netherlands > on 8 January 2014
162. Substance Abuse and Mental Health Services Administration, 2013. Results from the 2012 National Survey on Drug Use and Health: Summary of national findings. NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. US Department of Health and Human Services, Rockville, MD. Accessed at < http://www.samhsa. gov/data/NSDUH/2012SummNatFindDetTables/Index.aspx > on 4 April 2014.
163. B. Tempalski, E.R. Pouget, C.M. Cleland, J.E. Brady, H.L. Cooper, H.I. Hall, A. Lansky, B.S. West, and S.R. Friedman Trends in the population prevalence of people who inject drugs in US metropolitan areas 1992-2007 PLoS ONE 8 6 2013 e64789
164. The Scottish Government Hepatitis C Action Plan for Scotland: Phase II: May 2008-March 2011 2008 The Scottish Government Edinburgh Accessed at < http://www.scotland.gov.uk/Publications/2008/05/13103055/17 > on 10 January 2014
165. D.L. Thomas Global control of hepatitis C: where challenge meets opportunity Nat. Med. 19 7 2013 850 858
166. A.C. Thompson Releasing Prisoners, Redeeming Communities: Reentry, Race, and Politics 2008 New York University Press New York
167. N.D. Thompson, J.F. Perz, A.C. Moorman, and S.D. Holmberg Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008 Ann. Intern. Med. 150 1 2009 33 39
168. L.E. Thorpe, L.J. Ouellet, R. Hershow, S.L. Bailey, I.T. Williams, J. Williamson, E.R. Monterroso, and R.S. Garfein Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment Am. J. Epidemiol. 155 7 2002 645 653 (Pubitemid 34246097)
169. R. Tiger Judging Addicts: Drug Courts and Coercion in the Justice System 2013 New York University Press New York
170. J. Travis, B. Western, and F.S. Redburn National Research Council (U.S.). Committee on Law and Justice. The Growth of Incarceration in the United States: Exploring Causes and Consequences 2014 National Academies Press Washington, DC
171. F.C. Tseng, T.R. O'Brien, M. Zhang, A.H. Kral, B.A. Ortiz-Conde, J. Lorvick, M.P. Busch, and B.R. Edlin Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000 Hepatology 46 3 2007 666 671 (Pubitemid 47436111)
172. J. Turner, and W. Bunting A Living Death: Life without Parole for Nonviolent Offenses 2013 American Civil Liberties Union New York Accessed at < www.aclu.org/living-death-sentenced-die-behind-bars-what > on 8 January 2014
173. U.S. Department of Health and Human Services, 2014. Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis. Updated 2014-2016. Accessed at < http://aids.gov/news-and-events/hepatitis/ > on 12 April 2014.
174. UN Economic and Social Council, 2000. The Right to the Highest Attainable Standard of Health, General Comment No. 14. E/C.12/2000/4. Office of the United Nations High Commissioner for Human Rights, Geneva. Accessed at < http://www.unhchr.ch/tbs/doc.nsf/(symbol)/E.C.12.2000.4.En > on 3 February 2014.
175. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2009 2009 UNODC Vienna Accessed at < https://www.unodc.org/unodc/en/data-and- analysis/WDR-2009.html > on 30 January 2014
176. United Nations Office on Drugs and Crime 2005 World drug report 2005 United Nations Office on Drugs and Crime Vienna Accessed at < http://www.unodc.org/unodc/en/data-and-analysis/WDR-2005.html > on 3 February 2014
177. United Nations Office on Drugs and Crime Reducing the Adverse Health and Social Consequences of Drug Abuse: A comprehensive Approach 2008 United Nations Office on Drugs and Crime Vienna Accessed at < http://www.unodc.org/unodc/en/ frontpage/reducing-the-harm-of-drugs.html > on 28 January 2014
178. United Nations Office on Drugs and Crime Police Leadership in Harm Reduction and the HIV Response 2013 United Nations Office on Drugs and Crime Accessed at < https://www.unodc.org/middleeastandnorthafrica/en/web-stories/ police-leadership-in-harm-reduction-and-the-hiv-response.html > on 9 January 2014
179. United Nations Programme on HIV/AIDS (UNAIDS), and United Nations Office of the High Commissioner for Human Rights (UNHCR) International Guidelines on HIV/AIDS and Human Rights 2006 2006 UNAIDS Geneva, Switzerland Accessed at < http://data.unaids.org/Publications/IRC-pub07/jc1252-internguidelines-en.pdf >
180. L.C. van Boekel, E.P. Brouwers, J. van Weeghel, and H.F. Garretsen Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review Drug Alcohol Depend. 131 1-2 2013 23 35
181. C. Van Den Berg, C. Smit, G. Van Brussel, R. Coutinho, and M. Prins Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users Addiction 102 9 2007 1454 1462 (Pubitemid 47246988)
182. N. Walsh Addicted to Courts: How a Growing Dependence on Drug Courts Impacts People and Communities 2011 Justice Policy Institute Washington, DC Accessed at < http://www.justicepolicy.org/research/2217 > on 3 March 2014
183. World Health Organization, 1986. Ottawa Charter for Health Promotion. Accessed at < http://www.who.int/healthpromotion/conferences/previous/ottawa/ en/ > on 8 January 2014.
184. C. Wildeman, and B. Western Incarceration in fragile families Future Child. 20 2 2010 157 177
185. E. Wood, D. Werb, B.D. Marshall, J.S. Montaner, and T. Kerr The war on drugs: a devastating public-policy disaster Lancet 373 9668 2009 989 990
186. E. Wood, D. Werb, M. Kazatchkine, T. Kerr, C. Hankins, R. Gorna, D. Nutt, D. Des Jarlais, F. Barre-Sinoussi, and J. Montaner Vienna Declaration: a call for evidence-based drug policies Lancet 376 9738 2010 310 312
187. World Health Organization Constitution of the World Health Organization 1946 World Health Organization Geneva Accessed at < http://www.who.int/ governance/eb/constitution/en/ > on 3 March 2014
188. World Health Organization Guide to Starting and Managing Needle and Syringe Programmes 2007 World Health Organization, Joint United Nations Programme on HIV/AIDS, United Nations Office on Drugs and Crime Geneva Accessed at < http://www.who.int/hiv/pub/idu/needleprogram/en/index.html > on 10 January 2014
189. World Health Organization Guidance on Prevention of Viral Hepatitis B And C Among People Who Inject Drugs 2012 World Health Organization Geneva Accessed at < http://www.who.int/hiv/pub/guidelines/hepatitis/en/ > on 9 January 2014
190. World Health Organization Commission on Social Determinants of Health Closing the Gap in a Generation: Health Equity through Action on the Social Determinants of Health: Commission on Social Determinants of Health Final Report 2008 World Health Organization, Commission on Social Determinants of Health Geneva, Switzerland Accessed at < http://www.who.int/social-determinants/ thecommission/finalreport/en/index.html > on 10 January 2014
191. S. Yaphe, N. Bozinoff, R. Kyle, S. Shivkumar, N.P. Pai, and M. Klein Incidence of acute hepatitis C virus infection among men who have sex with men with and without HIV infection: a systematic review Sex. Transm. Infect. 88 7 2012 558 564
192. W.A. Zule, H.E. Cross, J. Stover, and C. Pretorius Are major reductions in new HIV infections possible with people who inject drugs? The case for low dead-space syringes in highly affected countries Int. J. Drug Policy 24 1 2013 1 7